Production (Stage)
Tiziana Life Sciences Ltd
TLSA
$1.58
$0.2115.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.55% | 20.55% | 45.99% | 45.99% | 16.63% |
| Total Depreciation and Amortization | 51.22% | 51.22% | 12.73% | 12.73% | -10.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 565.21% | 565.21% | 40.29% | 40.29% | -54.80% |
| Change in Net Operating Assets | -162.01% | -162.01% | 132.46% | 132.46% | 449.70% |
| Cash from Operations | 55.27% | 55.27% | 103.51% | 103.51% | 44.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -99,900.00% |
| Cash from Investing | 99.50% | 99.50% | -- | -- | -99,900.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 12.20% | 12.20% | -86.49% | -86.49% | -49.09% |
| Issuance of Common Stock | 18,484.00% | 18,484.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,697.44% | 5,697.44% | 76.29% | 76.29% | 113.76% |
| Foreign Exchange rate Adjustments | 101.61% | 101.61% | -334.18% | -334.18% | 71.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.91% | 147.91% | 99.54% | 99.54% | 35.71% |